Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells

Atherosclerosis

Volumn 112, Issue 1, 1995, Pages 69-76

  Chen, Y ^a   Morimoto, S ^a   Kitano, S ^a   Koh, E ^a   Fukuo, K ^a   Jiang, B ^a   Chen, S ^a   Yasuda, O ^a   Hirotani, A ^a   Ogihara, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

DNA synthesis; Intracellular calcium concentration; Lactate dehydrogenase release; Lysophosphatidylcholine; Smooth muscle cell

Indexed keywords

CALCIUM; DNA; LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINE; 3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; DILTIAZEM; ENZYME INHIBITOR; KT 5823; NICARDIPINE; VERAPAMIL;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FEMALE; METABOLISM; RAT; RAT STRAIN; VASCULAR SMOOTH MUSCLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; ETIOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMAL; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINES; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T;

EID: 0028985149     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(94)05400-D     Document Type: Article

References (28)

1. The low-density lipoprotein pathway and its relation to atherosclerosis
2. Replication of smooth muscle cells in vascular disease
3. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins
4. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
5. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
6. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein
7. Lysolecithin actions on vascular smooth muscle cells
8. The smooth muscle cells. II. Growth of smooth muscle in culture and formation of elastic fibers
9. 2+ indicators with greatly improved fluorescence properties
10. Lactic dehydrogenase activity in blood
11. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages
12. 2+ antagonist. 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscle
13. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases
14. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells
15. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine endothelial cells
16. Pertussis toxin inhibits the angiotensin II and serotonin-induced rise of free cytoplasmic calcium in cultured smooth muscle cells from rat aorta
17. 2α
18. 2+ influx in vascular smooth muscle cells
19. Molecular aggregation of the slow reacting memolytic lysolecithin analog 1-octadecyl-2-benzylglycero-3-phosphorylcholine in aqueous solution
20. Quantitative studies on lysolecithin-mediated hemolysis. Use of ether-deoxy lysolecithin analogs with varying aliphatic chain-lengths
21. Formosanin-C, an immunomodulator with antitumor activity
22. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes
23. Quantitative studies on translocation and metabolic conversion of lysophosphatidylcholine incorporated into the membrane of intact human erythrocytes from the medium
24. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
25. Transport of biological lipophiles: effect of lipophile structure
26. Metabolism of lysolecithin in vivo: effects of hyperlipidemia and atherosclerosis in squirrel monkey
27. Evidence that lysolecithin is an important causal agent of atherosclerosis
28. Atherosclerosis and biochemical composition of coronary arteries in Finnish men